Active, Not Recruiting
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study
NCT04071223
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +22 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Rush MD Anderson Cancer Center Chicago, Illinois, United States